Roundtable Discussion: Dissecting Development of Digital Measures Across CNS Clinical Development
Time: 11:40 am
day: Conference Day Two
Details:
Join tables led by digital biomarker experts to discuss the benefits and challenges of different digital measures of neurological disorders.
- Evaluating retinal eye motion as a prognostic biomarker for patient stratification and granular monitoring in CNS drug development
- Debating a standardized measurement package to streamline biomarker validation
- Balancing device and assessment sensitivity and usability to maximize quality of collected data
